Meyka Pro banner
Precipio, Inc.

Precipio, Inc. (PRPO) Stock Overview

Explore Precipio, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PRPONASDAQ
HealthcareMedical - Diagnostics & Research
$30.45
$1.02(3.47%)
U.S. Market opens in 58h 45m

Precipio, Inc. (PRPO)

Meyka AI Score

Z

Key Financials

Market Cap54.3M
P/E Ratio-45.46
EPS (TTM)$-0.26
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$27.12
3 Months$26.22
1 Year Target$33.64

PRPO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Precipio, Inc. (NASDAQ: PRPO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Precipio, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PRPO on the NASDAQ shows an RSI of 76.24, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $33.64 for the NASDAQ listing.

Key metrics behind Precipio, Inc.'s NASDAQ-traded stock include a P/E ratio of -45.46 and a market capitalization of 54.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PRPO on the NASDAQ.

Price Performance (NASDAQ: PRPO)

1-Day Change
3.47%
5-Day Change
31.02%
1-Month Change
28.48%
3-Month Change
23.98%
6-Month Change
20.07%
Year-to-Date (YTD) Change
32.51%
1-Year Change
110.00%
3-Year Change
299.61%
5-Year Change
-51.67%
All-Time (Max) Change
-98.87%

Contact Information

203 787 7888
4 Science Park, New Haven, CT, 06511

Company Facts

610 Employees
IPO DateJun 30, 2017
CountryUS
Actively Trading

Frequently Asked Questions